Cyclacel Pharmaceuticals logo

Cyclacel Pharmaceuticals Share Price Today

(NASDAQ: CYCC)

Cyclacel Pharmaceuticals share price is $0.34 & ₹29.57 as on 6 Mar 2025, 2.30 'hrs' IST

$0.34

0.01

(3.85%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cyclacel Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Cyclacel Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cyclacel Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Cyclacel Pharmaceuticals share price movements

  • Today's Low: $0.31
    Today's High: $0.35

    Day's Volatility :9.83%

  • 52 Weeks Low: $0.30
    52 Weeks High: $4.00

    52 Weeks Volatility :92.47%

Cyclacel Pharmaceuticals (CYCC) Returns

PeriodCyclacel Pharmaceuticals IncIndex (Russel 2000)
3 Months
-16.56%
0.0%
6 Months
-67.66%
0.0%
1 Year
-85.67%
0.0%
3 Years
-99.32%
-11.6%

Cyclacel Pharmaceuticals (CYCC) Key Statistics

in dollars & INR

Previous Close
$0.327
Open
$0.3172
Today's High
$0.3469
Today's Low
$0.3128
Market Capitalization
$4.5M
Today's Volume
$144.1K
52 Week High
$4.0
52 Week Low
$0.3014
Revenue TTM
$74.0K
EBITDA
$-15.5M
Earnings Per Share (EPS)
$-27.06
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-807.39%

How to invest in Cyclacel Pharmaceuticals Stock (CYCC) from India?

It is very easy for Indian residents to invest directly in Cyclacel Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cyclacel Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cyclacel Pharmaceuticals or CYCC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cyclacel Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cyclacel Pharmaceuticals shares which would translate to 2.558 fractional shares of Cyclacel Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cyclacel Pharmaceuticals, in just a few clicks!

Returns in Cyclacel Pharmaceuticals (CYCC) for Indian investors in Rupees

The Cyclacel Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cyclacel Pharmaceuticals investment value today

Current value as on today

₹19,295

Returns

₹80,705

(-80.71%)

Returns from Cyclacel Pharmaceuticals Stock

₹85,654 (-85.65%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Cyclacel Pharmaceuticals (CYCC)

-46%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cyclacel Pharmaceuticals Stock from India on INDmoney has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cyclacel Pharmaceuticals

  • Armistice Capital, LLC

    4.17%

  • UBS Group AG

    0.34%

  • TWO SIGMA SECURITIES, LLC

    0.21%

  • Point72 Asset Management, L.P.

    0.11%

  • Geode Capital Management, LLC

    0.08%

  • Tower Research Capital LLC

    0.04%

Analyst Recommendation on Cyclacel Pharmaceuticals

Buy

    77%Buy

    22%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Cyclacel Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Cyclacel Pharmaceuticals Stock (CYCC)

What analysts predicted

Upside of 194.12%

Target:

$1.00

Current:

$0.34

Insights on Cyclacel Pharmaceuticals Stock (Ticker Symbol: CYCC)

  • Price Movement

    In the last 6 months, CYCC stock has moved down by -68.0%
  • CYCC vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 152.2%
  • CYCC vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 151.0%
  • Price to Sales

    ForCYCC every $1 of sales, investors are willing to pay $10.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Cyclacel Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Cyclacel Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cyclacel Pharmaceuticals (CYCC) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cyclacel Pharmaceuticals Inc logo
-3.08%
-67.66%
-85.67%
-99.32%
-99.76%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cyclacel Pharmaceuticals Inc logo
NA
NA
0.0
0.0
-8.07
-1.09
NA
-0.45
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cyclacel Pharmaceuticals Inc logo
Buy
$4.5M
-99.76%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases in the United States, the United Kingdom, and internationally. The company's lead product includes fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors and hematological malignancies, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and Plogosertib, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced solid tumors and hematological malignancies. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. The company was founded in 1996 and is headquartered in Berkeley Heights, New Jersey.
Organization
Cyclacel Pharmaceuticals
Employees
0
CEO
Mr. Spiro George Rombotis
Industry
Health Technology

Management People of Cyclacel Pharmaceuticals

NameTitle
Mr. Spiro George Rombotis
President
Dr. Brian Schwartz M.D.
Chief Medical Officer
Mr. Cu Seng Kiu
Chief Financial Officer
Ms. Gill Christie
Director of Human Resources
Grace Kim
Investor Relations Executive

Important FAQs about investing in CYCC Stock from India :

What is Cyclacel Pharmaceuticals share price today?

Cyclacel Pharmaceuticals share price today stands at $0.34, Open: $0.32 ; Previous Close: $0.33 ; High: $0.35 ; Low: $0.31 ; 52 Week High: $4.00 ; 52 Week Low: $0.30.

The stock opens at $0.32, after a previous close of $0.33. The stock reached a daily high of $0.35 and a low of $0.31, with a 52-week high of $4.00 and a 52-week low of $0.30.

Can Indians buy Cyclacel Pharmaceuticals shares?

Yes, Indians can invest in the Cyclacel Pharmaceuticals (CYCC) from India.

With INDmoney, you can buy Cyclacel Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cyclacel Pharmaceuticals at zero transaction cost.

How can I buy Cyclacel Pharmaceuticals shares from India?

It is very easy to buy Cyclacel Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cyclacel Pharmaceuticals (CYCC) be purchased?

Yes, you can buy fractional shares of Cyclacel Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Cyclacel Pharmaceuticals stocks?

To start investing in Cyclacel Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cyclacel Pharmaceuticals Stock (CYCC)?

Today’s highest price of Cyclacel Pharmaceuticals (CYCC) is $0.35.

Today’s lowest price of Cyclacel Pharmaceuticals (CYCC) is $0.31.

What is today's market capitalisation of Cyclacel Pharmaceuticals?

Today's market capitalisation of Cyclacel Pharmaceuticals CYCC is 4.5M

What is the 52 Week High and Low Range of Cyclacel Pharmaceuticals Stock (CYCC)?

  • 52 Week High

    $4.00

  • 52 Week Low

    $0.30

What are the historical returns of Cyclacel Pharmaceuticals (CYCC)?

  • 1 Month Returns

    -3.08%

  • 3 Months Returns

    -67.66%

  • 1 Year Returns

    -85.67%

  • 5 Years Returns

    -99.76%

Who is the Chief Executive Officer (CEO) of Cyclacel Pharmaceuticals ?

Mr. Spiro George Rombotis is the current Chief Executive Officer (CEO) of Cyclacel Pharmaceuticals.